Peripheral arterial disease (PAD) affects more than 200 million people worldwide, with its most severe manifestation, chronic limb-threatening ischemia, potentially leading to imminent limb loss in up to 11% of patients.
Peripheral arterial disease (PAD) affects more than 200 million people worldwide, with its most severe manifestation, chronic limb-threatening ischemia, potentially leading to imminent limb loss in up to 11% of patients.
StageBio Director of Digital and Quantitative Pathology Thomas Lemarchand, DMV, DESV-AP, PhD, DECVP, recently co-authored a study that successfully demonstrated the effectiveness of a highly standardized porcine model for assessing dermal and epidermal wound healing.
Learn what triggers minimal Apoptosis/Single Cell Necrosis in nonhuman primate brain in this whitepaper coauthored by StageBio senior pathologist Dr. Joy Gary.
While the Marburg virus disease (MVD) is deadly to humans, the filovirus responsible for it—i.e., the Marburg virus (MARV)—is carried asymptotically in Egyptian rousette bats (ERBs).
The limitations of current PFO occluders According to the Mayo Clinic, approximately one in four people have a hole between the left and right chambers of the heart known as a patent foramen ovale, or PFO. First-generation PFO occluders were designed to stop any resulting blood flow between the two chambers.
StageBio scientists co-author study that demonstrate the benefit of 3D-printed scaffolds with geometric mismatches to treat periorbital bony defects
Currently, healthy animal models play a critical role in the safety evaluation of a drug or health product. However, pharmaceutical companies and regulatory authorities are becoming increasingly interested in the use of animal models of disease (AMD) to better understand the potential risk of a diseased population. Recent publications and recommendations for the use of these models by regulators make the growing interest of the application of AMD highly evident.
513.204.4400
